NO890644D0 - Fremgangsmaate for fremstilling av nye aspartat-transcarbamylase-inhibitorer. - Google Patents

Fremgangsmaate for fremstilling av nye aspartat-transcarbamylase-inhibitorer.

Info

Publication number
NO890644D0
NO890644D0 NO890644A NO890644A NO890644D0 NO 890644 D0 NO890644 D0 NO 890644D0 NO 890644 A NO890644 A NO 890644A NO 890644 A NO890644 A NO 890644A NO 890644 D0 NO890644 D0 NO 890644D0
Authority
NO
Norway
Prior art keywords
aspartat
procedure
preparation
new
transcarbamylase
Prior art date
Application number
NO890644A
Other languages
English (en)
Other versions
NO890644L (no
Inventor
Serge Halazy
Charles Danzin
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO890644D0 publication Critical patent/NO890644D0/no
Publication of NO890644L publication Critical patent/NO890644L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO89890644A 1988-02-16 1989-02-15 Fremgangsmaate for fremstilling av nye aspartat-transcarbamylase-inhibitorer. NO890644L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88400348A EP0328834A1 (en) 1988-02-16 1988-02-16 Novel aspartate transcarbamylase inhibitors

Publications (2)

Publication Number Publication Date
NO890644D0 true NO890644D0 (no) 1989-02-15
NO890644L NO890644L (no) 1989-08-17

Family

ID=8200350

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89890644A NO890644L (no) 1988-02-16 1989-02-15 Fremgangsmaate for fremstilling av nye aspartat-transcarbamylase-inhibitorer.

Country Status (12)

Country Link
EP (2) EP0328834A1 (no)
JP (1) JPH02149589A (no)
CN (1) CN1036207A (no)
AU (1) AU609942B2 (no)
DK (1) DK69489A (no)
FI (1) FI890695A (no)
HU (1) HUT49142A (no)
IL (1) IL89287A (no)
NO (1) NO890644L (no)
NZ (1) NZ227978A (no)
PT (1) PT89718B (no)
ZA (1) ZA891078B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE133678T1 (de) * 1990-07-04 1996-02-15 Merrell Dow Pharma 9-purinyl-phosphonsäurederivate
US5095007A (en) * 1990-10-24 1992-03-10 Ahluwalia Gurpreet S Alteration of rate and character of hair growth
GB9200826D0 (en) * 1992-01-15 1992-03-11 Celltech Ltd Peptidyl derivatives
WO2018052037A1 (ja) 2016-09-14 2018-03-22 ダイキン工業株式会社 分枝含フッ素化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3425701A1 (de) * 1984-07-12 1986-01-16 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von chlorierten phosphorylmethylcarbonyl-derivaten und neue zwischenprodukte zu ihrer herstellung
FR2590259B1 (fr) * 1985-11-20 1989-05-12 Roussel Uclaf Procede de preparation de derives fluores de l'acide phosphonique, et produits obtenus par la mise en oeuvre de ce procede
FR2596393B1 (fr) * 1986-04-01 1988-06-03 Sanofi Sa Derives de l'acide hydroxy-3 dihydroxyoxophosphorio-4 butanoique, leur procede de preparation, leur application comme medicament et les compositions les renfermant

Also Published As

Publication number Publication date
EP0328834A1 (en) 1989-08-23
HUT49142A (en) 1989-08-28
FI890695A0 (fi) 1989-02-14
AU2990489A (en) 1989-08-17
DK69489D0 (da) 1989-02-15
JPH02149589A (ja) 1990-06-08
PT89718A (pt) 1989-10-04
PT89718B (pt) 1994-03-31
IL89287A0 (en) 1989-09-10
IL89287A (en) 1993-02-21
NZ227978A (en) 1990-10-26
CN1036207A (zh) 1989-10-11
ZA891078B (en) 1989-10-25
FI890695A (fi) 1989-08-17
AU609942B2 (en) 1991-05-09
EP0331550A1 (en) 1989-09-06
NO890644L (no) 1989-08-17
DK69489A (da) 1989-08-17

Similar Documents

Publication Publication Date Title
NO891951D0 (no) Fremgangsmaate for fremstilling av nye hydroksamat-derivater.
NO892230L (no) Fremgangsmaate for fremstilling av nye alfa-glucosidaseinhibitorer.
NO903314L (no) Fremgangsmaate for fremstilling av nye peptidaseinhibitorer
NO892136D0 (no) Fremgangsmaate for fremstilling av nye peptider.
NO873091D0 (no) Fremgangsmaate for fremstilling av nye benzimidazolderivater.
NO902776L (no) Fremgangsmaate for fremstilling av nye acetylcholinesterase-inhibitorer.
NO904059D0 (no) Fremgangsmaate for fremstilling av nye substituerte isokinoliner.
NO892543L (no) Fremgangsmaate for fremstilling av nye neplanocinderivater.
NO901813L (no) Fremgangsmaate for fremstilling av nye tieno-triazolo-diazepin-derivater.
NO913391D0 (no) Fremgangsmaate for fremstilling av nye hetrazepinoide syreamider.
NO904372L (no) Fremgangsmaate for fremstilling av nye alfa-glucosidaseinhibitorer.
NO880851D0 (no) Fremgangsmaate for fremstilling av nye renin-inhibitorer.
NO892977D0 (no) Fremgangsmaate for fremstilling av nye s-adenosylmethionin-derivater.
NO904069L (no) Fremgangsmaate for fremstilling av nye alkanofenoner.
NO891381D0 (no) Fremgangsmaate for fremstilling av nye fluorfosfonatnukleotidderivater.
NO854577L (no) Fremgangsmaate for fremstilling av nye tienopyridinderivater.
NO911118D0 (no) Fremgangsmaate for fremstilling av nye 8-sulfamylmethylen-2-amino-tetraliner.
NO890644D0 (no) Fremgangsmaate for fremstilling av nye aspartat-transcarbamylase-inhibitorer.
NO872393L (no) Fremgangsmaate for fremstilling av nye aralkylimidazolderivater.
NO169590C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive sialosylglycerider
NO901422D0 (no) Fremgangsmaate for fremstilling av alfa-glucosidase-inhibitorer.
NO871721L (no) Fremgangsmaate for fremstilling av nye ergolenderivater.
NO893006D0 (no) Fremgangsmaate for fremstilling av nye allylaminoetylazoler
NO894967D0 (no) Fremgangsmaate for fremstilling av nye thrombolytiske proteiner.
NO902293D0 (no) Fremgangsmaate for fremstilling av nye tiazepinderivater.